Cargando…
Intravitreal Dexamethasone in Patients with Wet Age-Related Macular Degeneration Resistant to Anti-VEGF: A Prospective Pilot Study
PURPOSE: To evaluate the efficacy and safety of a single intravitreal dexamethasone implant (DXI) combined with intravitreal antivascular endothelial growth factor (anti-VEGF) therapy, in patients with neovascular age-related macular degeneration (wet-AMD) resistant to conventional treatment. METHOD...
Autores principales: | Giancipoli, Ermete, Pinna, Antonio, Boscia, Francesco, Zasa, Gianluigi, Sotgiu, Giovanni, Dore, Simone, D'Amico Ricci, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087571/ https://www.ncbi.nlm.nih.gov/pubmed/30151278 http://dx.doi.org/10.1155/2018/5612342 |
Ejemplares similares
-
Combined Phacoemulsification and Intravitreal Dexamethasone Implant (Ozurdex®) in Diabetic Patients with Coexisting Cataract and Diabetic Macular Edema
por: Furino, Claudio, et al.
Publicado: (2017) -
Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency and Late-stage Age-Related Macular Degeneration
por: Pinna, Antonio, et al.
Publicado: (2019) -
Efficacy of Intravitreal Dexamethasone Implant in Different Patterns of Diabetic Macular Edema
por: Furino, Claudio, et al.
Publicado: (2020) -
Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis
por: Ba, Jun, et al.
Publicado: (2015) -
Clinical Outcome and Drug Expenses of Intravitreal Therapy for Diabetic Macular Edema: A Retrospective Study in Sardinia, Italy
por: Altana, Chiara, et al.
Publicado: (2021)